Stay updated on Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; the previous revision v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:12:16.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added and v3.4.2 removed, indicating a minor page version update.
    Difference
    0.1%
    Check dated 2026-03-11T17:24:40.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removed Prostate cancer and the related topic MedlinePlus Genetics from the related topics section.
    Difference
    0.2%
    Check dated 2026-02-25T10:56:28.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The changes are minor site-wide notices: a new Revision: v3.4.2 appears, and prior notices about government funding and older revision v3.4.1 are removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:57:41.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added a general funding/operational notice and updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T04:47:48.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    UI updates include showing the glossary and adding related topics such as Prostate cancer and MedlinePlus Genetics, along with metadata label changes to Last Update Submitted that Met QC Criteria, No FEAR Act data, and Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-01-28T02:52:24.000Z thumbnail image

Stay in the know with updates to Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page.